Teng Sun

Prof. Dr. Teng Sun


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JLJia-Lei Li
Jia-Lei Li
YHYu Han
Yu Han
SWShuang Wang
Shuang Wang
XWXiaolei Wu
Xiaolei Wu
DWDe-Ping Wang
De-Ping Wang
TSTeng Sun
Teng Sun
Non-coding RNAs have been excavated as important cardiac function modulators and linked to heart diseases. Significant advances have been obtained in illuminating the effects of microRNAs and long non-coding RNAs. Nevertheless, the characteristics of circular RNAs are rarely mined. Circular RNAs (circRNAs) are widely believed to participate in cardiac pathologic processes, especially in myocardial infarction. In this review, we round up the biogenesis of circRNAs, briefly describe their biological functions, and summarize the latest literature on multifarious circRNAs related to new therapies and biomarkers for myocardial infarction.

26 January 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
TSTeng Sun
Teng Sun
JLJialei Li
Jialei Li
SWShuang Wang
Shuang Wang
YHYu Han
Yu Han
XTXiangyu Tao
Xiangyu Tao
DWDe-Ping Wang
De-Ping Wang
Programmed necrosis/necroptosis greatly contributes to the pathogenesis of cardiac disorders including myocardial infarction, ischemia/reperfusion (I/R) injury and heart failure. However, the fundamental mechanism underlying myocardial necroptosis, especially the mitochondria-dependent death pathway, is poorly understood. Synaptotagmin-1 (Syt1), a Ca2+ sensor, is originally identified in nervous system and mediates synchronous neurotransmitter release. The later findings of Syt1 expressions in many non-neuronal tissues including muscles suggest that Syt1 may exert important functions beyond regulation of neurotransmitter release. Syt1 is highly expressed in cardiomyocytes and has been used as an extracellular molecular probe for SPECT imaging of cardiac cell death in acute myocardial infarction. However, whether Syt1 functions in the pathogenesis of cardiac disorders and what is the molecular etiology have not yet been clarified. We showed here that Syt1 expression was significantly down-regulated in mice I/R injured heart tissues, H2O2-challenged cardiomyocytes and hypoxia/reoxygenation (H/R)-damaged cardiomyocytes. Enforced expression of Syt1 significantly inhibited myocardial necrotic cell death and interstitial fibrosis, and improved cardiac function in mice subjected to I/R operation. In exploring the underlying mechanisms, we found that Syt1 interacted with Parkin and promoted Parkin-catalyzed CypD ubiquitination, thus inhibited mitochondrial membrane permeability transition pore (mPTP) opening and ultimately suppressed cardiomyocyte necrosis. We further found that Syt1 expression was negatively regulated by miR-193b-3p. MiR-193b-3p regulated cardiomyocyte necrosis and mPTP opening by targeting Syt1. Our present work revealed a novel regulatory model of myocardial necrosis composed of miR-193b-3p, Syt1, Parkin, and CypD, which may provide potential therapeutic targets and strategies for heart protection.

17 October 2023 in The FEBS Journal
Verified
Journal Article
Closed access
TSTeng Sun
Teng Sun
YHYu Han
Yu Han
JLJia‐Lei Li
Jia‐Lei Li
SWShuang Wang
Shuang Wang
ZJZhi‐Jie Jing
Zhi‐Jie Jing
DWDe-Ping Wang
De-Ping Wang

12 February 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
JCJiasong Chang
Jiasong Chang
QLQi Li
Qi Li
TZTong Zhang
Tong Zhang
HSHao Sun
Hao Sun
ZJZhangrong Jia
Zhangrong Jia
DWDe-Ping Wang
De-Ping Wang

17 April 2025 in Molecules
Verified
Journal Article
Open access
PDF file
JCJiasong Chang
Jiasong Chang
YLYang xiu Long
Yang xiu Long
TZTong Zhang
Tong Zhang
SHSun Hao
Sun Hao
HCHongying Cheng
Hongying Cheng
DWDe-Ping Wang
De-Ping Wang
Genome editing is a promising therapeutic strategy for genetic disorders by modifying the genome precisely, especially the CRISPR/Cas9 system. However, a major limitation of CRISPR/Cas9 in gene therapy is the biosafety issues caused by off-target effects. Compounds that can modulate the genome editing efficiency of the CRISPR/Cas9 system, especially those reducing the off-target effects, are potentially useful pharmacological tools for improving the effectiveness and safety of genome editing. Here, we performed high-throughput screening in HEK 293FT cells to discover compounds that decrease or increase the genome editing efficiency of the CRISPR/Cas9 system from 9930 compounds. After two rounds of screening, we identified that CP-724714, a ErbB2 (HER2) tyrosine kinase inhibitor, decreased the CRISPR/Cas9 efficiency and reduced the off-target effects by suppressing the efficiency of CRISPR/Cas9, and was thus named a CRISPR decelerator (or inhibitor), while Clofarabine, a DNA synthesis inhibitor, increased the efficiency of CRISPR/Cas9, and was named a CRISPR accelerator. We further identified four compounds (Tranilast, Cerulenin, Rosolic acid and Resveratrol) that affected the efficiency of single-strand annealing (SSA) repair. Among them, Tranilast, Cerulenin and Rosolic acid are potential SSA decelerators, while Resveratrol is a potential SSA accelerator. These identified compounds may be useful in optimizing mammalian genetic manipulation techniques.

23 May 2025 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
TSTeng Sun
Teng Sun
JLJialei Li
Jialei Li
SWShuang Wang
Shuang Wang
YHYu Han
Yu Han
XTXiangyu Tao
Xiangyu Tao
DWDe-Ping Wang
De-Ping Wang